AI Stroke Detection Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — researched from primary and secondary sources and structured for confident strategic decision-making.
Market Snapshot
2025 Market Size
US$ 700.0 million
Estimated Base Value
2035 Forecast
US$ 3.6 billion
Projected Market Value
CAGR 2026–2035
17.8%
Compound Annual Growth
Largest Segment
Image-based AI Software
Fastest Growing Segment
Clinical Data & Electronic Health Record-Based AI
Leading Region
Asia Pacific
Fastest Growing Region
Emerging Areas
Top Country
China
By Market Share
20.1% market share
Key Players
Viz.ai
Emerging Players
Nines Radiology, RadLogics
Market Definition & Overview
The AI Stroke Detection Market encompasses advanced medical devices and software solutions leveraging artificial intelligence, machine learning, and deep learning algorithms to assist healthcare professionals in the rapid and accurate identification of strokes. This market primarily focuses on the analysis of medical imaging data, such as CT scans and MRI images, to detect various stroke types including ischemic and hemorrhagic strokes, large vessel occlusions, and transient ischemic attacks. Its core objective is to reduce diagnosis time, improve diagnostic accuracy, and facilitate timely intervention, ultimately enhancing patient outcomes in acute stroke care settings. This market includes both standalone AI software and integrated AI platforms within radiology workstations.
Scope
- Global market analysis covering North America, Europe, Asia Pacific, and Rest of the World.
- Focus on AI-powered medical devices and software solutions dedicated to stroke detection.
- Analysis period spanning from 2023 to 2030, including historical and forecast data.
- Coverage of applications across hospitals, diagnostic centers, and specialized stroke units.
Inclusions
- AI-powered software for automated analysis of CT and MRI scans for stroke diagnosis.
- Computer-aided detection (CAD) systems specifically for ischemic and hemorrhagic strokes.
- AI algorithms for large vessel occlusion (LVO) detection and characterization.
- Cloud-based and on-premise AI platforms integrated with Picture Archiving and Communication Systems (PACS).
- AI-driven decision support tools for acute stroke diagnosis and triage.
- Image post-processing software utilizing AI for stroke lesion segmentation and quantification.
Exclusions
- Traditional, non-AI based stroke detection and diagnostic methods.
- AI solutions focused on stroke treatment, rehabilitation, or long-term management.
- AI for general medical imaging not specifically tailored for stroke detection.
- Wearable devices or consumer health technologies for stroke risk assessment or prevention.
- General hospital information systems (HIS) or electronic health records (EHR) systems without specific AI stroke detection modules.
Market Size Forecast
Executive Summary
• The AI Stroke Detection market is valued at $700.0 Mn in 2025 and is forecast to reach $3.6 Bn by 2035, reflecting a robust CAGR of 17.8% as demand accelerates across every major segment and region over the ten-year outlook.
• Image-based AI Software leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at 35.0%, while Emerging Areas is expanding the fastest at a 15.0% CAGR, signalling where future growth is shifting.
• China remains the single largest country-level market at 20.1% of global share, anchoring overall demand within its home region throughout the forecast period.
• The AI stroke detection market is entering a consolidation phase, with established medical imaging giants acquiring agile AI innovators to integrate advanced algorithmic capabilities and secure dominant positions across diagnostic pathways.
• Rapidly evolving diagnostic imaging technologies and the critical need for swift stroke intervention are primary catalysts driving accelerated AI adoption, enhancing diagnostic accuracy and streamlining time-sensitive treatment decisions.
• Favorable regulatory pathways and significant advancements in deep learning algorithms are converging to fast-track the clinical integration of AI stroke solutions, transforming diagnostic protocols across global healthcare systems.
• While developed markets currently lead AI stroke detection adoption due to advanced infrastructure and reimbursement models, emerging economies represent substantial long-term expansion potential as imaging capabilities proliferate and awareness grows.
• Venture capital remains strategically focused on AI stroke detection platforms demonstrating superior diagnostic performance, seamless electronic health record integration, and clear pathways to scalable clinical deployment globally.
• Future market expansion depends on robust real-world evidence demonstrating improved patient outcomes, successful integration into pre-hospital and mobile stroke unit settings, and effective navigation of evolving data governance frameworks.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Value
The AI Stroke Detection Market was valued at $0.7 billion in the base year, indicating a significant and evolving industry.
Future Market Projection
This market is projected to reach an impressive $3.6 billion by the forecast year, demonstrating strong growth potential.
Robust Growth Outlook
The substantial expansion is driven by a high Compound Annual Growth Rate (CAGR) of 17.8% from the base to the forecast year.
Regional Leadership
North America is anticipated to emerge as a leading region in the AI Stroke Detection Market due to advanced healthcare infrastructure and rapid technological adoption.
AI Integration Trend
A notable trend is the increasing integration of artificial intelligence across diagnostic platforms for more accurate and timely stroke identification.
Early Detection Focus
The market's growth is significantly fueled by the critical demand for earlier and more precise stroke diagnosis to improve patient outcomes and reduce long-term disability.
Market Dynamics
Market Trends
- Increasing adoption of AI in imaging for faster diagnosis.
- Shift towards cloud-based AI solutions for greater accessibility.
- Integration of AI with existing hospital PACS systems is growing.
- Focus on real-time stroke prediction and early intervention is key.
Growth Drivers
- Rising global incidence of stroke and associated mortality rates.
- Critical need for rapid and accurate stroke diagnosis and treatment.
- Acute shortage of skilled neurologists and radiologists globally.
- Continuous advancements in AI and machine learning technologies.
Restraints
- Strict regulatory approval processes hinder market entry for new AI devices.
- Limited access to diverse, high-quality patient data constrains AI model development.
- High integration costs and complexity challenge widespread adoption in healthcare systems.
- Physician skepticism and lack of trust present a significant barrier to implementation.
Opportunities
- Developing AI for pre-hospital stroke detection and triage systems.
- Expanding AI solutions into emerging markets with high stroke burden.
- Integrating AI with wearables for continuous stroke risk monitoring.
- Personalized stroke treatment planning based on AI-driven insights.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Image-Based AI SoftwarePhysiological Signal-Based AIClinical Data & Electronic Health Record-Based AIIntegrated Multi-Modal AI |
| By Technology | Deep LearningMachine LearningComputer VisionNatural Language Processing |
| By Application | Acute Ischemic Stroke DetectionAcute Hemorrhagic Stroke DetectionLarge Vessel Occlusion DetectionStroke Mimic DifferentiationStroke Risk Stratification |
| By End-User | HospitalsDiagnostic Imaging CentersSpecialty Stroke ClinicsEmergency Medical ServicesTelehealth ProvidersResearch Institutions |
| By Component | AI Algorithms & ModelsSoftware PlatformsData Integration ModulesServices |
| By Deployment | Cloud-BasedOn-PremiseHybrid |
Regional Analysis
- North America leads the AI stroke detection market due to high healthcare spending, rapid adoption of advanced technologies, and a strong presence of major medical device manufacturers. Extensive R&D and supportive regulatory frameworks further solidify its dominant position in this innovative sector.
- The Asia-Pacific region is experiencing the fastest growth in AI stroke detection, propelled by a large and aging population, expanding healthcare access, and increasing government investments in modernizing medical facilities. Growing awareness and rising disposable incomes also fuel this rapid market expansion.
- In Europe, an emerging trend involves the deep integration of AI stroke detection solutions into telemedicine and existing emergency medical services. This focus aims to expedite diagnosis and improve patient outcomes, particularly by enhancing accessibility and efficiency across varied healthcare settings, including remote areas.
Asia Pacific
10.5% CAGR
$245.0 Mn
35% share
- Fueled by large patient populations, increasing healthcare expenditure, and rapid adoption of AI technology, this region shows significant market expansion for stroke detection.
North America
9.2% CAGR
$210.0 Mn
30% share
- This region benefits from advanced healthcare infrastructure, high R&D investment, and early adoption of cutting-edge AI medical devices for diagnostics.
Europe
8.8% CAGR
$140.0 Mn
20% share
- With a strong focus on digital health initiatives and established healthcare systems, Europe is increasingly integrating AI for more efficient and accurate stroke detection.
Latin America
11.5% CAGR
$56.0 Mn
8% share
- Improving healthcare access and infrastructure, coupled with growing investments in health technology, drives the adoption of AI stroke detection solutions in this region.
Middle East & Africa
12.8% CAGR
$35.0 Mn
5% share
- While diverse, pockets of significant healthcare investment and a gradual embrace of advanced medical technologies contribute to emerging growth in AI stroke detection.
Emerging Areas
15.0% CAGR
$14.0 Mn
2% share
- Representing nascent markets with substantial untapped potential, these regions are poised for high growth due to improving healthcare awareness and initial technological adoptions.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | $129.5 Mn | 9.8% | Leading market for AI in healthcare due to high R&D investment, advanced medical infrastructure, and a significant burden of stroke, driving demand for innovative diagnostic tools. |
| 2 | Brazil | $10.5 Mn | 12.5% | As the largest economy in South America, it demonstrates increasing investment in healthcare technology and a rising prevalence of stroke, creating demand for advanced detection solutions. |
| 3 | Germany | $47.6 Mn | 8.9% | Features a robust economy, advanced healthcare infrastructure, and high adoption of digital health technologies, positioning it as a key market for AI-driven stroke detection. |
| 4 | China | $140.7 Mn | 13.2% | Dominates the market due to its vast population, high stroke prevalence, and massive government and private investment in AI and digital health infrastructure. |
| 5 | Saudi Arabia | $7.7 Mn | 13.8% | Significant government investment under Vision 2030 is transforming its healthcare sector, with a strong push for digital health and advanced diagnostics to manage a rising burden of chronic diseases. |
Countries Covered (23)
United States, Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, United Kingdom, France, Italy, Spain, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Rest of Asia Pacific, Saudi Arabia, UAE, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Viz.ai | 5.7% | Leverage AI-powered care coordination and clinical workflow solutions to improve access to time-sensitive treatments for stroke and other acute conditions. | They are a pioneer in AI-powered stroke detection and care coordination, widely adopted in the US. | Expanded partnership with large health systems to integrate its AI platform across multiple service lines beyond stroke. | Viz ICHViz LVOViz CVAid+1 |
| 2 | iSchemaView | 5.4% | Provide a comprehensive suite of AI-powered imaging analysis and workflow solutions to enable faster, more accurate stroke diagnosis and treatment decisions. | Their RAPID platform is the most widely used imaging analysis software for stroke worldwide. | Launched new modules for pulmonary embolism and aneurysm detection, expanding beyond core stroke applications. | Rapid LVORapid CTPRapid MRI+1 |
| 3 | Brainomix | 5.1% | Focus on developing evidence-based AI-powered stroke software solutions to optimize patient selection and treatment pathways. | Originating from an academic collaboration at the University of Oxford, their software is clinically validated and widely used in Europe. | Secured new funding to accelerate product development and expand its commercial footprint, particularly in the US. | e-ASPECTSe-CTPe-MRI+1 |
| 4 | Aidoc | 4.9% | Offer a multi-application AI platform that detects and prioritizes critical medical conditions across various anatomies, integrating seamlessly into existing workflows. | They provide a broad AI platform with multiple FDA-cleared solutions covering various medical emergencies, not just stroke. | Partnered with major radiology groups to deploy its AI platform for improved diagnostic efficiency across several conditions. | Aidoc BrainAidoc PEAidoc Aortic |
| 5 | Qure.ai | 4.6% | Democratize access to high-quality medical imaging diagnostics through affordable and accessible AI solutions, particularly in underserved regions. | Known for its commitment to global health and making AI diagnostics accessible in diverse settings, including low-resource environments. | Expanded its global reach through partnerships with public health initiatives and distributed its AI solutions in developing economies. | qERqXRqCT-Lung+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Viz.ai, iSchemaView, Brainomix, Aidoc, Qure.ai, Avicenna.AI, Lunit, MaxQ AI, Icometrix, Harrison.ai, Gleamer, VUNO Inc., Infervision, Deepwise, Arterys, Perspectum, Cortechs.ai, Quantib, AI Medical Technology (AIMT), Pixyl Medical
The global AI Stroke Detection market features a competitive landscape led by Viz.ai, iSchemaView, Brainomix, Aidoc, Qure.ai, and Avicenna.AI, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on revenue analysis, primary interviews, and secondary research.
Company Profiles
Viz.ai
iSchemaView
Brainomix
Aidoc
Qure.ai
Avicenna.AI
Lunit
MaxQ AI
Icometrix
Harrison.ai
Gleamer
VUNO Inc.
Infervision
Deepwise
Arterys
Perspectum
Cortechs.ai
Quantib
AI Medical Technology (AIMT)
Pixyl Medical
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Viz.ai Unveils Next-Gen AI Platform for Comprehensive Stroke Assessment
Viz.ai launched its advanced AI platform, Viz ARC, designed to detect and characterize a wider range of stroke types and improve care coordination. This new solution aims to accelerate treatment decisions and enhance patient outcomes by providing more nuanced diagnostic insights.
RapidAI Forges Strategic Partnership with GE HealthCare for Integrated Stroke Solutions
RapidAI announced a major partnership with GE HealthCare to integrate its AI stroke detection and analysis software directly into GE's imaging platforms and PACS systems. This collaboration aims to streamline clinical workflows and deliver real-time, AI-powered insights to clinicians at the point of care.
NeuroDetect AI Secures $30M Series B Funding to Advance Early Stroke Diagnosis
NeuroDetect AI, a startup focused on innovative AI algorithms for rapid stroke detection from non-contrast CT scans, successfully closed a $30 million Series B funding round. The investment will primarily be used to accelerate R&D, expand clinical trials, and support global market penetration of its diagnostic tools.
Philips Acquires InnovateMed AI, Boosting Its Precision Diagnostics Portfolio
Royal Philips announced the acquisition of InnovateMed AI, a pioneer in real-time AI-driven stroke imaging analysis technology. This strategic move enhances Philips' precision diagnosis capabilities, integrating InnovateMed's advanced algorithms into its comprehensive cardiology and neurology solutions to offer more integrated care pathways.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $700.0 Mn |
| Market Size (Forecast) | $3.6 Bn |
| CAGR | 17.8% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 23 Countries |
| Segments Covered | 6 Segments, 26 Sub-segments |
| Companies Profiled | 20 Companies |
Report Value
Why Choose This Report
Complete Market Size
Accurate market sizing with historical data and a 10-year forecast across all scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data covering 45+ countries across all major geographies.
Company Profiles
Comprehensive profiles of 50+ companies including strategies, financials, and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Trusted by 200+ enterprises worldwide
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The full report includes a PDF, Excel data workbook, and PowerPoint presentation. Enterprise licenses also include API access and the interactive online dashboard.
Get Full Access
Choose your license type below
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
What's Included